|
KIAA1009 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.219870E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.403200E-03 |
| Normal-vs-Stage2 |
1.076350E-01 |
| Normal-vs-Stage3 |
1.587790E-01 |
| Normal-vs-Stage4 |
4.850000E-01 |
| Stage1-vs-Stage2 |
8.163600E-01 |
| Stage1-vs-Stage3 |
5.603400E-01 |
| Stage1-vs-Stage4 |
1.960990E-01 |
| Stage2-vs-Stage3 |
5.465000E-01 |
| Stage2-vs-Stage4 |
3.067800E-01 |
| Stage3-vs-Stage4 |
6.282800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.238800E-04 |
| Normal-vs-AfricanAmerican |
4.421100E-03 |
| Normal-vs-Asian |
4.956800E-01 |
| Caucasian-vs-AfricanAmerican |
9.509200E-01 |
| Caucasian-vs-Asian |
9.505800E-01 |
| AfricanAmerican-vs-Asian |
9.690200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.444200E-04 |
| Normal-vs-Female |
2.957900E-03 |
| Male-vs-Female |
7.972200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.664400E-02 |
| Normal-vs-Extreme_Weight |
2.268100E-02 |
| Normal-vs-Obese |
9.753300E-04 |
| Normal-vs-Extreme_Obese |
2.240600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.430200E-01 |
| Normal_Weight-vs-Obese |
1.552560E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.207200E-01 |
| Extreme_Weight-vs-Obese |
2.043800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.746800E-01 |
| Obese-vs-Extreme_Obese |
6.282200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.358000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.44889999997844E-06 |
| Normal-vs-Age(61-80Yrs) |
1.041520E-02 |
| Normal-vs-Age(81-100Yrs) |
6.399000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.184400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.878000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.602400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.185900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.217870E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.468560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.5557999999416E-08 |
| Normal-VS-Type2 PRCC |
5.827400E-01 |
| Normal-VS-KIRP CIMP |
9.538000E-01 |
| Normal-VS-Unclassified PRCC |
3.960100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.34079994171555E-10 |
| Type1 PRCC-VS-KIRP CIMP |
3.207200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.113450E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.207200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.788130E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.159900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.697000E-01 |
| Normal-vs-N1 |
1.014030E-02 |
| Normal-vs-N2 |
3.707000E-01 |
| N0-vs-N1 |
3.925900E-02 |
| N0-vs-N2 |
4.199400E-01 |
| N1-vs-N2 |
1.019960E-01 |
|
|
